Skip to main content
Premium Trial:

Request an Annual Quote

McGill Wins $1.4M Liver Disease Biomarker Study

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal has received a C$1.4 million (US$1.4 million) grant from a non-profit funding agency in Quebec to search for diagnostic biomarkers for two related liver conditions .

McGill will use the grant from a Fonds de la recherche en santé du Québec (FRSQ) competition to identify markers for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH), which are leading causes of chronic liver diseases.

NAFLD is frequently associated with obesity and affects about one third of the world's adult population. In about 25 percent of those adults the condition progresses to NASH, which leads to inflammation and damage.

Currently, there is no single reliable biochemical marker that can diagnose NAFLD or its progression to NASH and there are not many treatment options for the condition except for palliative care or liver transplant.

The four-year interdisciplinary studies will create a new competitive research program in translational research and seek to discover diagnostic markers to accurately identify patients with NAFLD and NASH, which "are urgently needed to provide cost-effective care," McGill said recently.

"One of the goals of our project is to identify new and valuable disease 'predictors' or biomarkers that will allow physicians to better understand and predict the progression of NAFLD and NASH," explained Tommy Nilsson, who is director of proteomics at The McGill University and Genome Quebec Innovation Centre and director of the Proteomics and Systems Medicine Program at RI-MUHC.

"These predictors could form the basis of new diagnostic tests or treatment options. If successful in liver disease, the methods used here could be applied to other complex diseases," Nilsson said.

"If successful, this work will create the road map to building personalized medicine programs across a spectrum of diseases that could lead to changes in healthcare delivery," added RI-MUHC Director Vassilos Papadopoulos.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.